• Aflac Incorporated recently announced it has been named a strategic Workday Wellness partner, allowing its supplemental health products and services to integrate with Workday’s AI-powered benefits platform to help employers refine benefit offerings and streamline administration.
• This collaboration directly targets a key friction in employer-sponsored benefits by using real-time data and AI-driven recommendations to address employees’ limited understanding and underuse of their coverage.
• We’ll now examine how Aflac’s integration into Workday’s AI-driven benefits ecosystem may influence its investment narrative around product innovation.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 24 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Aflac Investment Narrative Recap

To own Aflac, you generally need to believe in the long term demand for supplemental health coverage and the company’s ability to translate product and technology initiatives into stable earnings. The new Workday Wellness partnership aligns with that story, but it does not materially change the near term picture where pressured Japanese premiums and execution on digital efficiency remain the key catalyst and risk to watch.

Among recent announcements, Aflac’s continued share repurchases, including 9,331,364 shares bought back in Q3 2025, stand out alongside the Workday tie-in. While the partnership highlights product and distribution innovation, the ongoing buybacks frame how management is allocating capital while earnings growth and premium trends remain relatively modest compared with broader market expectations.

Yet investors should also be aware that Aflac’s heavy exposure to Japan leaves results highly sensitive to...

Aflac's narrative projects $18.5 billion revenue and $3.8 billion earnings by 2028. This requires 5.1% yearly revenue growth and a $1.4 billion earnings increase from $2.4 billion today.

Uncover how Aflac's forecasts yield a $111.31 fair value, in line with its current price.

Exploring Other Perspectives

Four members of the Simply Wall St Community value Aflac between US$98.64 and US$168.61, showing a wide span of fair value views. Against this, Aflac’s ongoing decline in Japanese net earned premiums raises important questions about how its core market may shape future performance, so you are well served by weighing several perspectives.

Explore 4 other fair value estimates on Aflac - why the stock might be worth as much as 54% more than the current price!

Build Your Own Aflac Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Aflac research is our analysis highlighting 2 key rewards that could impact your investment decision.
• Our free Aflac research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Aflac's overall financial health at a glance.

Interested In Other Possibilities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• Find companies with promising cash flow potential yet trading below their fair value.
• Explore 23 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.